Genotype and Intensive Pretreatment Influence Outcome of Acute Myeloid Leukemia Patients Treated With Venetoclax in Combination With Hypomethylating Agents or Low-dose Cytarabine: “Real World” Data From Germany

oleh: Krischan Braitsch, Laura K. Schmalbrock, Paul Jung, Irmgard Bumeder, Philipp Kiewe, Judith S. Hecker, Mareike Verbeek, Jörg Westermann, Lars Bullinger, Ulrich Keller, Florian Bassermann, Jan Krönke, Katharina S. Götze, Kathrin Rieger